Guidance on outcomes for joint clinical assessments
Clinical outcome assessments, used in clinical studies (whether they are interventional (also called experimental), or observational), are a key component of health technology assessment (HTA). They provide the estimate of the effectiveness of the targeted treatment on how patients feel, function, or survive, and the estimate of treatment safety.
The objectives of this guidance are twofold. The first objective is to provide guidance for Member States in defining relevant outcomes during the scoping process. The second is to help assessors and co-assessors in assessing and reporting all the elements that Member States need for the national appraisal of the clinical added value of a health technology.
Read the publication by EC Directorate-General for Health and Food Safety on 13 June 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (8 juillet 2024). Guidance on outcomes for joint clinical assessments. ELSIBI. Consulté le 11 janvier 2026 à l’adresse https://doi.org/10.58079/11ymt





